scispace - formally typeset
F

Fatima Mechta-Grigoriou

Researcher at PSL Research University

Publications -  81
Citations -  12972

Fatima Mechta-Grigoriou is an academic researcher from PSL Research University. The author has contributed to research in topics: Cancer & Tumor microenvironment. The author has an hindex of 32, co-authored 65 publications receiving 9825 citations. Previous affiliations of Fatima Mechta-Grigoriou include French Institute of Health and Medical Research & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress

TL;DR: JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS and provides new insights into the regulation of PHD activity, allowing immediate reactive adaptation to changes in O2 or iron levels in the cell.
Journal ArticleDOI

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.

TL;DR: Show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity and the role of miR200a in stress could be a predictive marker for clinical outcome in ovarian cancer.